Use of Funds
All funds raised will be used exclusively and transparently for the development of this drug.
Stage 1
$1,500,000 — Drug Manufacturing
$1,150,000 — Safety/Toxicology Studies (Mouse)
$1,050,000— Studies (monkey PK/PD)
$650,000— IND Preparation

Stage 1 Subtotal: $4,350,000
Stage 2
Phase 1 Clinical Trial
$700,000 — Administrative staff
$750,000 — Clinical procedure
$25,000 — Data management
$50,000 — Patient recruitment
$10,000 — Patient retention
$500,000 — Physicians
$750,000 — RN/CRA
$275,000 — Site monitoring
$240,000 — Site recruitment
$200,000 — Site retention
$300,000 — CRO Fees

Stage 2 Subtotal: $3,800,000
Stage 2
Phase 2 Clinical Trial Elements
$3,300,000 — Administrative staff
$4,700,000 — Clinical procedure
$850,000 — Data management
$1,800,000 — Patient recruitment
$650,000 — Patient retention
$950,000 — Physicians
$1,500,000 — RN/CRA
$2,800,000 — Site monitoring
$750,000 — Site recruitment
$3,400,000 — Site retention
$3,400,000 — CRO Fees

Stage 3 Subtotal: $24,100,000
Total Program
$33,250,000